A
Abridge
Health Tech & Medtech · Pittsburgh, United States · Founded 2018 Unicorn
Investors
32 investors on Abridge's cap table
Sourced from Dealroom's funding history. Investor profile links are shown where available.
Ownership
Who owns Abridge
Estimated cap table from Dealroom's shareholder data — share of equity by holder. Stakes as last recorded by Dealroom (2026). Percentages are indicative.
Some investors are hidden on this public profile. See the full cap table on Dealroom →
Global footprint
Where Abridge has talent and traffic
team presence
across markets
Talent graph
The shape of Abridge's talent
Dealroom maps Abridge's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.
Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.
Patent intelligence
$12k patent portfolio · 3 active families
Where Abridge concentrates vs peers
Each axis is a top-10 topic across Abridge and its closest peers. #1 = 100, #10 = 10, absent = 0.
Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.
Market sentiment
What the market is saying about Abridge
An AI-synthesized read of the highest-engagement posts about Abridge on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Abridge on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.